EUVIMEDEUVIMED entdecken
Systematische Übersicht

xCT (Slc7a11) Regulation: Lessons from Cancer Research

Sravika Chirla, Rahul Pandit, Zila Martinez-Lozada

Neurochemical Research · 2026-06 · 51 (3)

DOI: 10.1007/s11064-026-04776-w ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neurochemical Research, online erschienen am 18.05.2026. Verfasst von Sravika Chirla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology and Neuroscience, Nova Southeastern University, Davie, FL, USA. Hauptthemen laut MEDLINE: Amino Acid Transport System y+, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: International Society of Neurochemistry, Nova Southeastern University, International Brain Research Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cystine/glutamate antiporter, also known as system Xc-, has two roles: (1) imports cystine used to form glutathione (GSH), (2) regulates the extracellular concentration of glutamate. These roles are essential for brain function, as GSH is the most important antioxidant in the brain, and glutamate is the main excitatory neurotransmitter. This antiporter is composed of two subunits: xCT (encoded by the gene Slc7a11) and a heavy chain, CD98 (encoded by the gene Slc3a2). xCT is the subunit responsible for cystine/glutamate transport, while CD98 is responsible for the translocation of system Xc- to the membrane. The antioxidant function of xCT has been highlighted by the discovery of ferroptosis, a distinctive form of programmed cell death triggered by lipid peroxidation and the accumulation of reactive oxygen species. In addition, numerous types of cancers have been shown to overexpress xCT to evade ferroptosis. The mechanisms by which healthy cells regulate xCT expression, the mechanisms responsible for xCT overexpression in cancer cells, and whether different types of cancers employ identical mechanisms to upregulate xCT have not been systematically studied. To answer these questions, we conducted a systematic review to consolidate the regulatory mechanisms governing xCT expression. We found that xCT expression is regulated at nearly all known levels, including epigenetic, transcriptional, post-transcriptional, translational, post-translational, and by protein-protein interactions, with some cell-type- and context-specific mechanisms. Overall, our work highlights the role of xCT and the breadth of axes through which its expression can be modulated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acid Transport System y+NeoplasmsHumansAnimalsGene Expression Regulation, NeoplasticReactive Oxygen SpeciesFerroptosis

Stichwörter der Autor:innen

CancerCystine/glutamate antiporterGlutamate transportSlc7a11xCT

Substanzen

Amino Acid Transport System y+SLC7A11 protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Psychology and Neuroscience, Nova Southeastern University, Davie, FL, USA.
  • Department of Psychology and Neuroscience, Nova Southeastern University, Davie, FL, USA. zmartine@nova.edu.

Förderung

  • International Society of Neurochemistry
  • Nova Southeastern University
  • International Brain Research Organization

Zitieren

APA

Chirla, S., Pandit, R., & Martinez-Lozada, Z. (2026). xCT (Slc7a11) Regulation: Lessons from Cancer Research. Neurochemical Research, 51(3). https://doi.org/10.1007/s11064-026-04776-w

Vancouver

Chirla S, Pandit R, Martinez-Lozada Z. xCT (Slc7a11) Regulation: Lessons from Cancer Research. Neurochemical Research. 2026;51(3). doi:10.1007/s11064-026-04776-w

BibTeX
@article{Chirla2026,
  author = {Chirla, Sravika and Pandit, Rahul and Martinez-Lozada, Zila},
  title = {xCT (Slc7a11) Regulation: Lessons from Cancer Research},
  journal = {Neurochemical Research},
  year = {2026},
  volume = {51},
  number = {3},
  doi = {10.1007/s11064-026-04776-w}
}
Kostenlos starten →